Adicet Bio (ACET) FCF Margin (2019 - 2022)
Adicet Bio (ACET) posted quarterly FCF Margin of 5.89% for Q1 2022, up 40288.0% year-over-year from N/an in Q1 2021, and up 102.98% quarter-over-quarter from 197.82% in Q4 2021.
Adicet Bio (ACET) FCF Margin (2019 - 2022) Analysis & Trends
Adicet Bio's FCF Margin history runs 4 years deep, the most recent figure standing at 5.89% for Q1 2022.
- In Q1 2022, FCF Margin rose 40288.0% year-over-year to 5.89%; the TTM figure through Dec 2022 stood at 175.41% (up 11291.0% YoY), while the FY2022 annual figure was 175.41%, up 34884.0% from the prior year.
- FCF Margin for Q1 2022 stood at 5.89%, up from 197.82% in the prior quarter.
- The five-year high for FCF Margin was 81.1% in Q3 2019, with the low at 39385.71% in Q4 2019.
- The 4-year median for FCF Margin is 254.18% (2021), against an average of 3781.85%.
- Peak annual rise in FCF Margin reached 3912215 bps in 2020, while the deepest fall reached 32922 bps in 2020.
- Adicet Bio's FCF Margin stood at 39385.71% in 2019, then soared by 99 bps to 263.57% in 2020, then increased by 25 bps to 197.82% in 2021, then surged by 103 bps to 5.89% in 2022.
- Business Quant data shows ACET's FCF Margin at 5.89% in Q1 2022, 197.82% in Q4 2021, and 354.42% in Q3 2021.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 30.39% |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 13.35% |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -388.28% |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 25.68% |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 22.62% |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 41.07% |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -22.35% |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 70.82% |
| 10 | Adicet Bio | 98.21 Mn | -19.98 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2022 | 5.89% |
| Dec 31, 2021 | -197.82% |
| Sep 30, 2021 | -354.42% |
| Jun 30, 2021 | -254.18% |
| Mar 31, 2021 | -396.99% |
| Dec 31, 2020 | -263.57% |
| Sep 30, 2020 | -248.12% |
| Jun 30, 2020 | -165.40% |
| Mar 31, 2020 | -421.15% |
| Dec 31, 2019 | -39,385.71% |
| Sep 30, 2019 | 81.10% |